Bishal Gyawali

Bishal Gyawali at Queen's is a Nepali-Canadian oncologist who has become an influential voice in global oncology policy, particularly regarding value in cancer care and the critical evaluation of cancer drug approvals. His analyses of surrogate endpoint validity in cancer approvals, on the clinical significance thresholds used in regulatory decisions, and his advocacy for affordable cancer care in resource-limited settings have challenged the oncology community to think critically about evidence quality and equitable access.